0.77

0.34% -0.005

Karyopharm Therapeutics Inc (KPTI)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$0.775

Aprire:

$0.76

Volume 24 ore:

229.32K

Relative Volume:

0.31

Capitalizzazione di mercato:

$97.09M

Reddito:

$140.46M

Utile/perdita netta:

$-146.34M

Rapporto P/E:

-0.5833

EPS:

-1.32

Flusso di cassa netto:

$-117.73M

1 W Prestazione:

-7.75%

1M Prestazione:

-9.60%

6M Prestazione:

-31.04%

1 anno Prestazione:

+4.63%

Intervallo 1D:

$0.76

$0.798

Intervallo di 1 settimana:

$0.7518

$0.8886

Portata 52W:

$0.6174

$1.95

Karyopharm Therapeutics Inc Stock (KPTI) Company Profile

Nome

Karyopharm Therapeutics Inc

Settore

Healthcare (1195)

Industria

Biotechnology (683)

Telefono

617-658-0600

Indirizzo

85 WELLS AVENUE, NEWTON, MA

Dipendente

325

Cinguettio

@Karyopharm

Prossima data di guadagno

2024-11-05

Ultimi documenti SEC

KPTI's Discussions on Twitter

Confronta KPTI con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
KPTI	0.77	97.09M	140.46M	-146.34M	-117.73M	-1.32
VRTX	449.33	115.43B	10.63B	-479.80M	-1.35B	13.33
REGN	749.22	82.04B	13.85B	4.65B	3.32B	35.06
ARGX	588.35	35.30B	1.86B	-40.29M	-1.28B	-4.16
ALNY	247.58	32.04B	2.09B	-332.26M	16.06M	-4.14
BNTX	106.96	24.89B	3.30B	-501.07M	1.03B	11.54

Karyopharm Therapeutics Inc Stock (KPTI) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2023-01-19	Iniziato	Piper Sandler	Overweight
2022-11-04	Aggiornamento	RBC Capital Mkts	Sector Perform → Outperform
2022-02-09	Aggiornamento	JP Morgan	Underweight → Neutral
2021-11-19	Ripresa	Morgan Stanley	Equal-Weight
2021-08-06	Downgrade	JP Morgan	Overweight → Neutral
2021-08-06	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
2021-08-06	Downgrade	SVB Leerink	Outperform → Mkt Perform
2020-07-02	Iniziato	Morgan Stanley	Overweight
2020-03-04	Iniziato	Barclays	Overweight
2020-01-17	Downgrade	Wedbush	Outperform → Neutral
2019-07-23	Aggiornamento	JP Morgan	Neutral → Overweight
2019-07-05	Reiterato	H.C. Wainwright	Buy
2019-07-05	Reiterato	Robert W. Baird	Outperform
2019-03-01	Downgrade	JP Morgan	Overweight → Neutral
2019-02-28	Reiterato	BofA/Merrill	Underperform
2019-02-27	Downgrade	BofA/Merrill	Neutral → Underperform
2019-01-03	Aggiornamento	BofA/Merrill	Underperform → Neutral
2018-12-03	Iniziato	B. Riley FBR	Buy
2018-11-09	Aggiornamento	Wedbush	Neutral → Outperform
2018-05-24	Downgrade	Wedbush	Outperform → Neutral
2018-04-02	Ripresa	Leerink Partners	Outperform
2017-11-15	Ripresa	H.C. Wainwright	Buy
2017-09-15	Iniziato	RBC Capital Mkts	Outperform
2016-09-08	Reiterato	H.C. Wainwright	Buy
2016-08-30	Aggiornamento	Jefferies	Hold → Buy
2016-08-18	Iniziato	H.C. Wainwright	Buy
2016-06-28	Iniziato	Robert W. Baird	Outperform

Mostra tutto

Karyopharm Therapeutics Inc Borsa (KPTI) Ultime notizie

03:42 AM

Karyopharm appoints new chief accounting officer By Investing.com - Investing.com UK

Nov 20, 2024

Karyopharm Therapeutics Inc. Appoints Kristin Abate as Chief Accounting Officer - Marketscreener.com

Nov 20, 2024

Nov 18, 2024

Karyopharm to Present New Selinexor Clinical Data at ASH 2024 Annual Meeting | KPTI Stock News - StockTitan

Nov 18, 2024

Nov 15, 2024

Avidity Partners Management LP's Strategic Acquisition of Karyop - GuruFocus.com

Nov 15, 2024

Nov 14, 2024

Karyopharm Therapeutics' SWOT analysis: stock outlook amid pipeline progress By Investing.com - Investing.com Nigeria

Nov 14, 2024

Karyopharm Therapeutics' SWOT analysis: stock outlook amid pipeline progress - Investing.com India

Nov 14, 2024

Karyopharm Therapeutics (NASDAQ:KPTI) Stock Rating Upgraded by StockNews.com - MarketBeat

Nov 14, 2024

GSA Capital Partners LLP Purchases 792,283 Shares of Karyopharm Therapeutics Inc. (NASDAQ:KPTI) - MarketBeat

Nov 14, 2024

Nov 08, 2024

Leerink Partnrs Issues Optimistic Forecast for KPTI Earnings - MarketBeat

Nov 08, 2024

What is HC Wainwright's Estimate for KPTI FY2024 Earnings? - MarketBeat

Nov 08, 2024

Karyopharm Therapeutics Falls To US$0.88, But Insiders Sold At Lower Price - Simply Wall St

Nov 08, 2024

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock? - Yahoo Finance

Nov 08, 2024

Karyopharm Therapeutics (NASDAQ:KPTI) Stock Price Expected to Rise, Piper Sandler Analyst Says - Defense World

Nov 08, 2024

Karyopharm Therapeutics Reports Q3 2024 Financial Results and Corporate Progress - Defense World

Nov 08, 2024

Nov 07, 2024